141 related articles for article (PubMed ID: 27792904)
1. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3.
Incrocci R; Barse L; Stone A; Vagvala S; Montesano M; Subramaniam V; Swanson-Mungerson M
Virology; 2017 Jan; 500():96-102. PubMed ID: 27792904
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module.
Engels N; Merchant M; Pappu R; Chan AC; Longnecker R; Wienands J
J Exp Med; 2001 Aug; 194(3):255-64. PubMed ID: 11489945
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.
Lan YY; Hsiao JR; Chang KC; Chang JS; Chen CW; Lai HC; Wu SY; Yeh TH; Chang FH; Lin WH; Su IJ; Chang Y
J Virol; 2012 Jun; 86(12):6656-67. PubMed ID: 22514348
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency.
Fruehling S; Swart R; Dolwick KM; Kremmer E; Longnecker R
J Virol; 1998 Oct; 72(10):7796-806. PubMed ID: 9733815
[TBL] [Abstract][Full Text] [Related]
5. Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas.
Hatton O; Lambert SL; Krams SM; Martinez OM
PLoS One; 2012; 7(8):e42610. PubMed ID: 22880054
[TBL] [Abstract][Full Text] [Related]
6. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway.
Swart R; Ruf IK; Sample J; Longnecker R
J Virol; 2000 Nov; 74(22):10838-45. PubMed ID: 11044134
[TBL] [Abstract][Full Text] [Related]
7. Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity.
Rovedo M; Longnecker R
J Virol; 2007 Jan; 81(1):84-94. PubMed ID: 17035319
[TBL] [Abstract][Full Text] [Related]
8. Role of the immunoreceptor tyrosine-based activation motif of latent membrane protein 2A (LMP2A) in Epstein-Barr virus LMP2A-induced cell transformation.
Fukuda M; Kawaguchi Y
J Virol; 2014 May; 88(9):5189-94. PubMed ID: 24554661
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) Enhances ATP Production in B Cell Tumors through mTOR and HIF-1α.
Incrocci R; Monroy Del Toro R; Devitt G; Salimian M; Braich K; Swanson-Mungerson M
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612754
[TBL] [Abstract][Full Text] [Related]
10. Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for C-terminal Src kinase.
Scholle F; Longnecker R; Raab-Traub N
J Virol; 1999 Jun; 73(6):4767-75. PubMed ID: 10233937
[TBL] [Abstract][Full Text] [Related]
11. The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility.
Allen MD; Young LS; Dawson CW
J Virol; 2005 Feb; 79(3):1789-802. PubMed ID: 15650203
[TBL] [Abstract][Full Text] [Related]
12. Two Pathways of p27
Sora RP; Ikeda M; Longnecker R
mBio; 2019 Apr; 10(2):. PubMed ID: 30992353
[TBL] [Abstract][Full Text] [Related]
13. Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway.
Fukuda M; Longnecker R
J Virol; 2004 Feb; 78(4):1697-705. PubMed ID: 14747535
[TBL] [Abstract][Full Text] [Related]
14. Emerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorder.
Hatton O; Martinez OM; Esquivel CO
Pediatr Transplant; 2012 May; 16(3):220-9. PubMed ID: 22353174
[TBL] [Abstract][Full Text] [Related]
15. Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications.
Chen J
World J Virol; 2012 Dec; 1(6):154-61. PubMed ID: 24175221
[TBL] [Abstract][Full Text] [Related]
16. A bacterial effector protein promotes nuclear translocation of Stat3 to induce IL-10.
Berneking L; Bekere I; Rob S; Schnapp M; Huang J; Ruckdeschel K; Aepfelbacher M
Eur J Cell Biol; 2023 Dec; 102(4):151364. PubMed ID: 37806297
[TBL] [Abstract][Full Text] [Related]
17. Study on the regulatory mechanism of latent membrane protein 2A on GCNT3 expression in nasopharyngeal carcinoma.
Chen Y; Zhang Y; Duo S; Liu W; Luo B
Virus Genes; 2024 May; ():. PubMed ID: 38739247
[TBL] [Abstract][Full Text] [Related]
18. Janus kinase inhibitors ameliorate clinical symptoms in patients with STAT3 gain-of-function.
Kaneko S; Sakura F; Tanita K; Shimbo A; Nambu R; Yoshida M; Umetsu S; Inui A; Okada C; Tsumura M; Yamada M; Suzuki H; Kosaki K; Ohara O; Shimizu M; Morio T; Okada S; Kanegane H
Immunother Adv; 2023; 3(1):ltad027. PubMed ID: 38549698
[TBL] [Abstract][Full Text] [Related]
19. The Potential Role of Virus Infection in the Progression of Thyroid Cancer.
Wu YK; Jiang TT; Su YH; Mei L; Sun TK; Li YH; Wang ZD; Ji YY
World J Oncol; 2024 Jun; 15(3):382-393. PubMed ID: 38751704
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the Role of Epstein-Barr Virus Latent Membrane Protein 1 in Immune Modulation: A Multifaced Signalling Perspective.
Šimičić P; Batović M; Stojanović Marković A; Židovec-Lepej S
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]